MX2009012743A - Agente novedoso para salificar principios activos en apositos que contienen por lo menos una sustancia grasa. - Google Patents

Agente novedoso para salificar principios activos en apositos que contienen por lo menos una sustancia grasa.

Info

Publication number
MX2009012743A
MX2009012743A MX2009012743A MX2009012743A MX2009012743A MX 2009012743 A MX2009012743 A MX 2009012743A MX 2009012743 A MX2009012743 A MX 2009012743A MX 2009012743 A MX2009012743 A MX 2009012743A MX 2009012743 A MX2009012743 A MX 2009012743A
Authority
MX
Mexico
Prior art keywords
salting out
fatty substance
active principles
out active
novel agent
Prior art date
Application number
MX2009012743A
Other languages
English (en)
Inventor
Christelle Laurensou
Original Assignee
Urgo Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Urgo Lab filed Critical Urgo Lab
Publication of MX2009012743A publication Critical patent/MX2009012743A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/46Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/02Adhesive bandages or dressings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016Disaccharides, e.g. lactose, lactulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/785Polymers containing nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/20Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/225Mixtures of macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/44Medicaments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0052Mixtures of macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061Use of materials characterised by their function or physical properties
    • A61L26/0066Medicaments; Biocides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • A61P23/02Local anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602Type of release, e.g. controlled, sustained, slow

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invención se refiere al uso, como un agente para salificar una sustancia activa en una composición para un apósito, de un copolímero de una sal de ácido 2-metil-2-[(1-oxo-2-propenil)amino]-1-propansulfónico y de éster de 2-hidroxietilpropenoato; se refiere también a apósitos del tipo que comprenden por lo menos una sustancia grasa y/o una matriz elastomérica y por lo menos una sustancia activa, que incorpora el copolímero mencionado anteriormente.
MX2009012743A 2007-05-25 2008-05-23 Agente novedoso para salificar principios activos en apositos que contienen por lo menos una sustancia grasa. MX2009012743A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0755272A FR2916356B1 (fr) 2007-05-25 2007-05-25 Nouvel agent permettant le relargage d'actifs dans des pansements contenant au moins un corps gras
PCT/FR2008/050893 WO2008149036A1 (fr) 2007-05-25 2008-05-23 Nouvel agent permettant le relargage d'actifs dans des pansements contenant au moins un corps gras

Publications (1)

Publication Number Publication Date
MX2009012743A true MX2009012743A (es) 2010-03-15

Family

ID=38834511

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009012743A MX2009012743A (es) 2007-05-25 2008-05-23 Agente novedoso para salificar principios activos en apositos que contienen por lo menos una sustancia grasa.

Country Status (19)

Country Link
US (1) US10500301B2 (es)
EP (1) EP2148703B1 (es)
JP (1) JP5290277B2 (es)
KR (1) KR101445900B1 (es)
CN (1) CN101678146B (es)
AT (1) ATE482726T1 (es)
AU (1) AU2008259661B2 (es)
BR (1) BRPI0811948B8 (es)
CA (1) CA2687731C (es)
DE (1) DE602008002835D1 (es)
DK (1) DK2148703T3 (es)
ES (1) ES2353851T3 (es)
FR (1) FR2916356B1 (es)
HK (1) HK1140972A1 (es)
MX (1) MX2009012743A (es)
PL (1) PL2148703T3 (es)
PT (1) PT2148703E (es)
RU (1) RU2448737C2 (es)
WO (1) WO2008149036A1 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2916355B1 (fr) * 2007-05-25 2009-08-28 Urgo Soc Par Actions Simplifie Nouveau principe actif dans la cicatrisation et son utilisation
GB0808376D0 (en) 2008-05-08 2008-06-18 Bristol Myers Squibb Co Wound dressing
GB0817796D0 (en) 2008-09-29 2008-11-05 Convatec Inc wound dressing
GB201020236D0 (en) 2010-11-30 2011-01-12 Convatec Technologies Inc A composition for detecting biofilms on viable tissues
ES2748519T3 (es) 2010-12-08 2020-03-17 Convatec Technologies Inc Accesorio de sistema de exudado de heridas
US10207031B2 (en) 2010-12-08 2019-02-19 Convatec Technologies Inc. Integrated system for assessing wound exudates
FR2973223B1 (fr) * 2011-03-31 2013-04-19 Urgo Lab Pansement absorbant cicatrisant, ses utilisations pour les plaies chroniques
PL2524706T3 (pl) 2011-05-19 2014-12-31 Lohmann & Rauscher Gmbh & Co Kg Sterylne opatrunki ran z syntetycznym elastomerem trój-blokowym
EP2524705B1 (de) * 2011-05-19 2014-04-23 Lohmann & Rauscher GmbH & Co. KG Sterile Wundauflage mit einem synthethischen Dreiblock-Elastomer und einem hydrophorbierten polymeren Biguanid
GB201115182D0 (en) 2011-09-02 2011-10-19 Trio Healthcare Ltd Skin contact material
GB2497406A (en) 2011-11-29 2013-06-12 Webtec Converting Llc Dressing with a perforated binder layer
GB201120693D0 (en) 2011-12-01 2012-01-11 Convatec Technologies Inc Wound dressing for use in vacuum therapy
FR2993182B1 (fr) 2012-07-13 2014-10-17 Urgo Lab Pansement a liberation prolongee d'actifs
KR20150099776A (ko) 2012-12-20 2015-09-01 컨바텍 테크놀러지스 인크 화학적 개질된 셀룰로스 섬유의 처리
FR3037788B1 (fr) * 2015-06-29 2022-01-21 Urgo Lab Nouveau pansement absorbant antimicrobien
EP3936095B1 (en) 2016-03-30 2024-06-19 ConvaTec Technologies Inc. Detecting microbial infections in wounds
JP2019513238A (ja) 2016-03-30 2019-05-23 クオリザイム・ダイアグノスティクス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング・ウント・コムパニー・コマンディットゲゼルシャフトQualizyme Diagnostics Gmbh And Co. Kg 創傷における微生物感染の検出
TW201805034A (zh) 2016-07-08 2018-02-16 美商康瓦鐵克科技股份有限公司 彈性的負壓系統
CA3030151A1 (en) 2016-07-08 2018-01-11 Convatec Technologies Inc. Fluid collection apparatus
AU2017292028B2 (en) 2016-07-08 2023-03-02 Convatec Technologies Inc. Fluid flow sensing
FR3068974B1 (fr) * 2017-07-12 2019-08-02 Urgo Recherche Innovation Et Developpement Pansement permettant la liberation controlee et prolongee d'actif
FR3068975B1 (fr) * 2017-07-12 2020-07-17 Urgo Recherche Innovation Et Developpement Composition pour pansement interface
CN108029925A (zh) * 2017-12-29 2018-05-15 常德金德新材料科技股份有限公司 一种基于短周期即食品的天然防霉材料及制备方法
CN109793919B (zh) * 2019-02-01 2022-01-14 明基材料(芜湖)有限公司 硫化氢缓释敷料及其制造方法
US11771819B2 (en) 2019-12-27 2023-10-03 Convatec Limited Low profile filter devices suitable for use in negative pressure wound therapy systems
US11331221B2 (en) 2019-12-27 2022-05-17 Convatec Limited Negative pressure wound dressing

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2446793A (en) * 1945-07-04 1948-08-10 Wm S Merrell Co Substituted pyridinium and piperidinium compounds
US3929741A (en) * 1974-07-16 1975-12-30 Datascope Corp Hydrophilic acrylamido polymers
GB1576522A (en) * 1977-05-24 1980-10-08 Colorplast International A S Sealing material for ostomy devices
DK147035C (da) 1980-12-05 1984-09-03 Coloplast As Hudplade
US4912093A (en) * 1986-10-01 1990-03-27 Marion Laboratories, Inc. Use of synthetic sulfated saccharides to enhance wound healing
DK154747C (da) 1986-10-17 1989-05-08 Coloplast As Bandage med en hudvenlig, vandabsorberende klaebeskive der paa den ene flade er fast forbundet med en ikke-klaebende daekfilm og paa den anden med et aftageligt beskyttelsesdaekke
DK154806C (da) 1986-12-19 1989-06-26 Coloplast As Saarplejemiddel indeholdende et aktivt stof til fremme af saarbehandlingen og fremgangsmaade til fremstilling deraf
US5681579A (en) * 1993-03-22 1997-10-28 E.R. Squibb & Sons, Inc. Polymeric support wound dressing
US5968001A (en) 1996-05-14 1999-10-19 Bristol-Myers Squibb Company Wound dressings with leak prevention seal
FR2753380B1 (fr) * 1996-09-16 1998-12-04 Lhd Lab Hygiene Dietetique Nouvelle masse adhesive hydrophile
FR2782086B1 (fr) * 1998-08-04 2000-12-01 Seppic Sa Nouveau latex epaississant a base d'acide 2-methyl 2-[(1-oxo 2-propenyl) amino] 1-propanesulfonique, copolymerise avec l'acrylate de (2-hydroxyethyle), procede de preparation et applications en cosmetique
JP4440466B2 (ja) * 1998-01-16 2010-03-24 ソシエテ・デクスプロワタシオン・デ・プロデュイ・プール・レ・アンデュストリー・シミック・セピック 濃縮ラテックス、製造プロセスおよび化粧品としての用途
FR2775903B1 (fr) * 1998-03-12 2001-06-08 Lhd Lab Hygiene Dietetique Masse hydrocolloide a absorption accrue des les premieres heures d'utilisation
GB2341185A (en) 1998-09-07 2000-03-08 Polybiomed Ltd Polymerizable material and adhesive sheet material therefrom; dressings, electrodes and transdermal patches
FR2783412B1 (fr) * 1998-09-18 2000-12-15 Lhd Lab Hygiene Dietetique Compresse non adherente sterile
US5970515A (en) 1998-09-23 1999-10-26 Fishbaugh; Brenda B. Protective eyewear
US20020197302A1 (en) * 1998-11-12 2002-12-26 Cochrum Kent C. Hemostatic polymer useful for rapid blood coagulation and hemostasis
FR2806629B1 (fr) * 2000-03-22 2003-01-24 Lhd Lab Hygiene Dietetique Compresse antiseptique
DE60233217D1 (de) * 2001-05-01 2009-09-17 Corium Internat Inc Hydrogel-zusammensetzungen
JP2003300856A (ja) * 2002-04-05 2003-10-21 Fancl Corp 化粧料組成物
KR100529209B1 (ko) * 2002-08-28 2005-11-17 한국과학기술연구원 세포 친화성이 향상된 생분해성의 조직 공학용 다공성고분자 지지체의 제조방법
US20040241215A1 (en) * 2003-05-20 2004-12-02 Lipman Roger D. A. Multi-dressing system for managing skin wounds
US20060018852A1 (en) * 2003-08-22 2006-01-26 L'oreal Compositions containing topical active agents and pentylene glycol
JP2008504916A (ja) 2004-07-16 2008-02-21 コロプラスト アクティーゼルスカブ 創傷治療具
JP5102944B2 (ja) 2005-06-08 2012-12-19 ロート製薬株式会社 皮膚外用剤
JP2009040685A (ja) * 2005-11-04 2009-02-26 Toagosei Co Ltd 貼付剤
US7851633B2 (en) * 2006-06-09 2010-12-14 Beiersdorf Ag Piperidinium compounds and cosmetic compositions containing them
FR2916355B1 (fr) * 2007-05-25 2009-08-28 Urgo Soc Par Actions Simplifie Nouveau principe actif dans la cicatrisation et son utilisation

Also Published As

Publication number Publication date
JP5290277B2 (ja) 2013-09-18
US10500301B2 (en) 2019-12-10
BRPI0811948B8 (pt) 2021-06-22
EP2148703A1 (fr) 2010-02-03
ATE482726T1 (de) 2010-10-15
EP2148703B1 (fr) 2010-09-29
ES2353851T3 (es) 2011-03-07
HK1140972A1 (en) 2010-10-29
CN101678146A (zh) 2010-03-24
CA2687731C (fr) 2015-04-28
AU2008259661A1 (en) 2008-12-11
DE602008002835D1 (de) 2010-11-11
CN101678146B (zh) 2012-11-21
KR101445900B1 (ko) 2014-09-29
FR2916356B1 (fr) 2009-08-28
PL2148703T3 (pl) 2011-06-30
BRPI0811948A2 (pt) 2014-10-14
RU2448737C2 (ru) 2012-04-27
PT2148703E (pt) 2010-12-14
BRPI0811948B1 (pt) 2018-07-17
CA2687731A1 (fr) 2008-12-11
JP2010527977A (ja) 2010-08-19
FR2916356A1 (fr) 2008-11-28
RU2009147169A (ru) 2011-06-27
DK2148703T3 (da) 2011-01-10
KR20100016275A (ko) 2010-02-12
AU2008259661B2 (en) 2013-05-09
WO2008149036A1 (fr) 2008-12-11
US20100285129A1 (en) 2010-11-11

Similar Documents

Publication Publication Date Title
MX2009012743A (es) Agente novedoso para salificar principios activos en apositos que contienen por lo menos una sustancia grasa.
NZ708247A (en) Hyaluronic acid based formulations
EP1880719A3 (en) Composition for prophylaxis or treatment of urinary system infection and method thereof
BRPI0516857A (pt) dispositivos biomédicos que contêm copolìmeros de bloco anfifìlico
MX2009004038A (es) Gel de diclofenaco.
UA111464C2 (uk) Композиція, що містить моногліцериди органічних кислот c1-c7 та гліцерин, та її застосування як протибактеріального та протипліснявого засобу
TW200740799A (en) Alpha2C adrenoreceptor agonists
CO6650415A2 (es) Nuevas formas de dosificacion de liberación modificada de un inhibidor de la xantina oxidorreductasa o de inhibidoes de xantina oxidasa
PL1962815T3 (pl) Zastosowanie błonotwórczych polimerów do pielęgnacji włosów z grupy poluretanów i zawierające te polimery preparaty i plastry farmaceutyczne
EA017091B9 (ru) Фумаратная соль (альфа s, бета r)-6-бром-альфа-[2-(диметиламино)этил]-2-метокси-альфа-1-нафталенил-бета-фенил-3-хинолинэтанола
CL2007003060A1 (es) Compuestos derivados de piridazina; proceso para la preparacion de dichos compuestos; composicion fungicida para controlar o proteger contra microorganismos fitopatogenicos;uso de dichos compuestos; y metodo para controlar o proteger contra microorganismos fitopatogenicos.
DK1791428T3 (da) Sammensætning til behandling af såsæd
MX2009012742A (es) Ingrediente activo novedoso en cicatrizacion y uso del mismo.
MX2012006629A (es) Microorganismos probioticos como agentes activos contra cambios en microrelieve de la piel.
SG10201406288SA (en) Multimeric forms of antimicrobial peptides
WO2010149283A3 (de) Phenyloxy(thio)phenylamidbenzoxa(thia)zole
WO2013004982A3 (fr) Procédés de traitement cosmétique et kit
CL2012003521A1 (es) Derivado piperidino (r)-n-((r)-1-((3s-4s)-4-(4-clorofenil)-3,4-dihidroxi-3-metilpiperidin-1-il)-3-metil-1-oxobutan-2-il)-3,3-difluorociclopentanocarboxamida, modulador receptor quimiocinas; composicion farmaceutica; y uso del compuesto y su composicion en enfermedades inflamatorias y autoinmunitarias, entre otras.
TW200621773A (en) Bicyclononene derivatives
HK1112721A1 (en) Tissue disruption treatment and composition for use thereof
BR112012007842A2 (pt) um copolímero em bloco e composição de poliesteramida com terminação éster e usos dos mesmos
UA96794C2 (ru) Глюкокортикоиды, способ их применения, способ лечения и фармацевтическая композиция на их основе
TW200628468A (en) Bicyclononene derivatives
WO2011163069A3 (en) Protease triggered release of molecules from hydrogels
JO3684B1 (ar) صور متبلرة من الملح ثنائي الصوديوم لحمض n-(5-كلورو ساليسلويل)-8-امينو كابريليك

Legal Events

Date Code Title Description
FG Grant or registration